You just read:

Phase 2b Findings Published In The New England Journal Of Medicine Demonstrate Significant Efficacy Of Guselkumab In Treatment Of Moderate To Severe Plaque Psoriasis

News provided by

Janssen Research & Development, LLC

Jul 08, 2015, 05:00 ET